Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ibanez

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Nature Aging|November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseIlana Caro, Daniel Western, Shinichi Namba, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 31, 2017
Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approachMohamed Abdulkadir, Douglas Londono, Derek Gordon, et al.
Research Square|July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseStephanie Debette, Ilana Caro, Daniel Western, et al.
Stroke|December 15, 2020
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day OutcomeLaura Heitsch, Laura Ibanez, Caty Carrera, et al.
Brain : a Journal of Neurology|February 4, 2025
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onsetHaiyan Liu, Thomas W Marsh, Xinyu Shi, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
JAMA Neurology|April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical TrialOlivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Journal of Psychiatric Research|August 6, 2016
Pre- and perinatal complications in relation to Tourette syndrome and co-occurring obsessive-compulsive disorder and attention-deficit/hyperactivity disorderMohamed Abdulkadir, Jay A Tischfield, Robert A King, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Nature Aging|November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseIlana Caro, Daniel Western, Shinichi Namba, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 31, 2017
Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approachMohamed Abdulkadir, Douglas Londono, Derek Gordon, et al.
Research Square|July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseStephanie Debette, Ilana Caro, Daniel Western, et al.
Stroke|December 15, 2020
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day OutcomeLaura Heitsch, Laura Ibanez, Caty Carrera, et al.
Brain : a Journal of Neurology|February 4, 2025
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onsetHaiyan Liu, Thomas W Marsh, Xinyu Shi, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
JAMA Neurology|April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical TrialOlivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Journal of Psychiatric Research|August 6, 2016
Pre- and perinatal complications in relation to Tourette syndrome and co-occurring obsessive-compulsive disorder and attention-deficit/hyperactivity disorderMohamed Abdulkadir, Jay A Tischfield, Robert A King, et al.
Pageof 11